AIG
DAWN

American International Group’s Day One Biopharmaceuticals DAWN Stock Holding History

American International Group’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,877
Closed -$510K – 716
2024
Q1 		$510K Sell
30,877
-265
-0.9% -$3.97K ﹤0.01% 1637
2023
Q4 		$455K Sell
31,142
-126
-0.4% -$1.53K ﹤0.01% 1715
2023
Q3 		$384K Buy
31,268
+7,571
+32% +$98.8K ﹤0.01% 1749
2023
Q2 		$283K Buy
23,697
+10,333
+77% +$135K ﹤0.01% 1977
2023
Q1 		$179K Buy
13,364
+267
+2% +$5.22K ﹤0.01% 2176
2022
Q4 		$282K Sell
13,097
-48
-0.4% -$985 ﹤0.01% 1937
2022
Q3 		$263K Buy
13,145
+2,216
+20% +$47.1K ﹤0.01% 1992
2022
Q2 		$196K Sell
10,929
-365
-3% -$3.77K ﹤0.01% 2191
2022
Q1 		$112K Buy
11,294
+5,434
+93% +$71.8K ﹤0.01% 2553
2021
Q4 		$99K Sell
5,860
-175
-3% -$3.6K ﹤0.01% 2721
2021
Q3 		$143K Buy
+6,035
New +$145K ﹤0.01% 2618

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American International Group's DAWN Position: Q2 2024 in Review

American International Group sold out of Day One Biopharmaceuticals (DAWN) in Q2 2024, closing a stake of 30,877 shares — an estimated $510K sold.

American International Group first reported a position in DAWN in Q3 2021 and held it in 11 quarters. The position peaked at $510K in Q1 2024. 156 funds tracked by Wall St. Rank hold DAWN as of Q2 2024.

  • American International Group reported no remaining Day One Biopharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 30,877 Day One Biopharmaceuticals shares in Q2 2024, an estimated $510K.
  • American International Group first reported a position in Day One Biopharmaceuticals in Q3 2021 and held it in 11 quarters.
  • American International Group's Day One Biopharmaceuticals position peaked at $510K in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.